The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Allergy Relief
Allergy Relief · FEXOFENADINE HYDROCHLORIDE 180 mg/1 · Tablet · Oral · Allegiant Health
NDC 69168-0450-06 · 120 TABLET in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- ANDA204097
- TE code
- —
- Approval date
- Aug 19, 2016
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Allergy Relief (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Allegiant Health | FEXOFENADINE HYDROCHLORIDE 180 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| GM Pharmaceuticals, INC | CHLOPHEDIANOL HYDROCHLORIDE 25 mg/1; PYRILAMINE MALEATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Good Sense | DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Allergy Relief — NDC 69168-0450-06," retrieved September 3, 2026, https://drugdashboards.com/drug/69168045006.
Free to cite with attribution — see how the data is put together.